[Comparative clinical study of the efficacy of and tolerance for lysine para-isobutylphenyl propionate in parallel with indomethacin and pyrasanone].
D000328:Adult; D000368:Aged; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007052:Ibuprofen / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use*; D008239:Lysine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy; D013997:Time Factors
C100279:pyrazinobutazone; D010653:Phenylbutazone; D008239:Lysine; C016106:solufenum; D007052:Ibuprofen; D007213:Indomethacin
Studio clinico comparativo sull'efficacia e tollerabilità del para-iso9butilfenil propionato di lisina in parallelo con indometacina e pirasanone.